Ajai Chari, MD

Articles by Ajai Chari, MD

Thomas Martin, MDVideo Insights | September 19, 2023
The panel discussed the FDA-approved bispecific agents for myeloma and how the options performed in clinical trials.
View More
Larysa Sanchez, MDMyeloma | May 2, 2023
This editorial outlines key practical points for the use of talquetamab in relapsed or refractory MM. 
Ajai Chari, MDVideo Insights | December 27, 2022
Ajai Chari, MD, of Mount Sinai School of Medicine, discusses results from the MonumenTAL-1 phase I/II study of talquetamab.